Croop R, Lipton RB, Kudrow D, Stock DA, et al. Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial. Lancet 2020 Dec 15. pii: S0140-6736(20)32544.
PMID: 33338437